This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2008-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2014
Title: The Innovations of Andreas Rosenwald
Introduction
Andreas Rosenwald is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of chronic lymphocytic leukemia and small lymphocytic lymphoma through his innovative research and patents. With a total of 3 patents, Rosenwald's work has had a profound impact on the understanding and treatment of these diseases.
Latest Patents
One of his latest patents focuses on ZAP-70 expression as a marker for chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL). It has been surprisingly found that ZAP-70 expression, both at the protein and mRNA levels, is indicative of clinical subgroups of CLL/SLL patients. In particular, high ZAP-70 expression is indicative of Ig-unmutated CLL/SLL. Methods are provided for discriminating between clinical subgroups of CLL/SLL by determining whether subjects overexpress ZAP-70 mRNA or protein.
Career Highlights
Andreas Rosenwald is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to explore groundbreaking research in the field of hematology and oncology.
Collaborations
Rosenwald has collaborated with esteemed colleagues such as Louis M Staudt and Wyndham H Wilson. These partnerships have further enhanced the quality and impact of his research.
Conclusion
Andreas Rosenwald's contributions to the field of chronic lymphocytic leukemia and small lymphocytic lymphoma through his patents and research are invaluable. His work continues to influence the medical community and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile